3 hours ago
1
Pgiam/iStock via Getty Images
Amicus Therapeutics (NASDAQ:FOLD) traded higher on Thursday after Morgan Stanley upgraded the stock, citing a favorable setup for the company ahead of a key ruling in its patent dispute with generic drug maker Aurobindo, as well as the potential for its
English (US) ·